Suppression of gonadotropins and estradiol in premenopausal women by oral administration of the nonpeptide gonadotropin-releasing hormone antagonist elagolix.
Saved in:
| Title: | Suppression of gonadotropins and estradiol in premenopausal women by oral administration of the nonpeptide gonadotropin-releasing hormone antagonist elagolix. |
|---|---|
| Authors: | Struthers RS; Neurocrine Biosciences Inc., 12780 El Camino Real, San Diego, California 92130, USA. sstruthers@neurocrine.com, Nicholls AJ, Grundy J, Chen T, Jimenez R, Yen SS, Bozigian HP |
| Source: | The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2009 Feb; Vol. 94 (2), pp. 545-51. Date of Electronic Publication: 2008 Nov 25. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0021-972X (Print) Linking ISSN: 0021972X NLM ISO Abbreviation: J Clin Endocrinol Metab Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
